Hashimoto Disease and Celiac Disease: When to Screen and Why It Matters
Hashimoto patients have roughly 3-7 times higher risk of celiac disease than the general population. Screening with tTG-IgA plus total IgA is reasonable at diagnosis or with persistent symptoms. If celiac is confirmed, a strict lifelong gluten-free diet is required and can improve levothyroxine absorption. If celiac is absent, gluten avoidance does not meaningfully improve thyroid outcomes per current evidence.
Why Hashimoto and celiac cluster together
Hashimoto thyroiditis and celiac disease are two of the most common organ-specific autoimmune diseases, and they share a deep biological substrate. Both are driven by HLA class II susceptibility alleles (particularly HLA-DQ2 and HLA-DQ8 for celiac, with overlapping haplotypes implicated in autoimmune thyroid disease), shared T-cell regulatory defects, and a common pattern of breakdown in self-tolerance [C3][C4]. When one organ-specific autoimmune disease is present, the lifetime probability of a second rises substantially — the "autoimmune cluster" pattern.
A 2016 meta-analysis pooling studies across more than 8,000 patients found that the prevalence of biopsy-proven celiac disease in patients with autoimmune thyroid disease was roughly 1.6–4.3%, translating to a 3-7 fold higher relative risk versus the general population (where prevalence sits near 0.5–1%) [C1]. Newer narrative reviews and the 2026 NEJM-style review of celiac disease echo this: autoimmune thyroid disease is one of the strongest non-GI associations of celiac, and clustering is well established [C3][C4].
The reverse is also true. In adults newly diagnosed with celiac disease, the prevalence of autoimmune thyroid disease — Hashimoto in particular — is several-fold higher than expected, and routine thyroid screening at celiac diagnosis is recommended by major GI societies [C2][C4].
Why missed celiac matters for thyroid control
The most clinically actionable reason to think about celiac in Hashimoto patients is levothyroxine absorption. Levothyroxine is absorbed primarily in the jejunum and upper ileum — exactly the segments damaged by untreated celiac disease. Villous atrophy reduces the absorptive surface and disrupts the local pH and bile-acid environment needed for tablet dissolution and uptake [C2][C3].
The clinical pattern is recognizable: a Hashimoto patient whose TSH refuses to come into range despite weight-appropriate dosing, escalating levothyroxine without obvious cause, or who needs an unusually high dose for their body weight. In published cohorts, the levothyroxine requirement falls — sometimes by 20–30% — after celiac diagnosis and several months of a gluten-free diet, as the mucosa heals and absorption normalizes [C2][C3][C5].
This is the strongest pragmatic argument for screening: it changes both the diagnosis and the dose.
The screening protocol
The standard screening test, recommended by major GI societies, is serum tissue transglutaminase IgA antibody (tTG-IgA) plus a total IgA level to rule out selective IgA deficiency (which is itself over-represented in autoimmune disease and would produce a false-negative tTG-IgA) [C4]. The test must be done while the patient is still eating gluten — going gluten-free before testing produces false negatives within weeks.
The typical workflow looks like this [C4]:
- tTG-IgA negative + normal total IgA: celiac unlikely; no further workup unless symptoms strongly suggest it.
- tTG-IgA positive (especially >10x upper limit): refer to gastroenterology. In adults, confirmatory duodenal biopsy is still the standard for diagnosis. (Pediatric guidelines have moved toward biopsy-sparing diagnosis at very high antibody titers, but adult guidance retains biopsy as the reference standard.)
- Total IgA low or undetectable: order IgG-based tests (deamidated gliadin peptide IgG or tTG-IgG) as the alternative serology.
Who to screen, and when [C3][C4]:
- At Hashimoto diagnosis, particularly in patients with GI symptoms, iron-deficiency anemia, unexplained osteoporosis, or a first-degree relative with celiac.
- At any point if TSH remains elevated despite adequate levothyroxine dosing or the dose required is unexpectedly high for body weight.
- In children and adolescents with Hashimoto, since growth failure and silent celiac are more common.
- In adults with persistent fatigue, brain fog, or anemia despite a normal TSH on levothyroxine.
Routine biennial re-screening of all Hashimoto patients is not standard; targeted screening based on the triggers above is the current approach [C3][C4].
What does NOT help (and where the evidence is misread)
A common misunderstanding is that everyone with Hashimoto should be on a gluten-free diet. The published evidence does not support that claim.
- In confirmed celiac disease, a strict lifelong gluten-free diet is mandatory and improves levothyroxine absorption, mucosal healing, and long-term outcomes [C2][C4][C5]. This is not optional.
- In Hashimoto patients without celiac, the picture is different. A 2022 systematic review specifically on TSH and anti-thyroid antibodies in autoimmune thyroiditis patients on a gluten-free diet found no consistent, clinically meaningful improvement in TSH or thyroid antibody titers attributable to gluten avoidance alone [C5]. A 2023 meta-analysis in patients with autoimmune thyroiditis but no celiac symptoms or histology reached similar conclusions: small antibody changes in a few studies, no reliable effect on thyroid function [C6]. A 2025 systematic review and meta-analysis specifically of gluten-free diet in non-celiac Hashimoto patients concluded that current evidence does not support routine gluten avoidance for thyroid outcomes [C7].
In short: gluten-free is the treatment for celiac, not a treatment for Hashimoto. Patients without celiac who feel better off gluten may be responding to wider dietary changes, placebo, or non-celiac gluten sensitivity — none of which are the same as celiac disease and none of which have been shown to modify Hashimoto's natural history.
Practical guidelines
- Screen with tTG-IgA plus total IgA at Hashimoto diagnosis if GI symptoms, iron-deficiency anemia, unexplained osteoporosis, or a first-degree relative with celiac is present [C3][C4].
- Screen if levothyroxine isn't working as expected — persistently elevated TSH despite weight-appropriate dosing, or an unusually high dose requirement [C2][C8].
- Stay on gluten while testing. Going gluten-free before serology and biopsy can produce false negatives within weeks [C4].
- Refer for duodenal biopsy if antibodies are positive (in adults). The biopsy remains the diagnostic reference in adult practice [C4].
- If celiac is confirmed, commit to a strict lifelong gluten-free diet and recheck TSH 6-8 weeks after starting — the levothyroxine dose often needs to be reduced as absorption improves [C2][C5][C8].
- If celiac is excluded, do not adopt a gluten-free diet to treat Hashimoto. Current systematic reviews do not show meaningful thyroid benefit, and the diet adds cost and social burden [C5][C6][C7].
Frequently asked questions
How much higher is my celiac risk if I have Hashimoto? Meta-analyzed prevalence in autoimmune thyroid disease populations sits around 1.6–4.3%, versus about 0.5–1% in the general population — a 3-7 fold increase [C1][C3].
Should I screen for celiac even if I have no GI symptoms? Many adults with celiac have minimal or no classic GI symptoms ("silent" or "subclinical" celiac). Screening is reasonable at Hashimoto diagnosis, especially in the presence of unexplained iron-deficiency anemia, refractory TSH, or a first-degree relative with celiac [C3][C4].
Will going gluten-free improve my TSH if I do not have celiac? Current systematic reviews and meta-analyses do not show a consistent, clinically meaningful effect of gluten-free diets on TSH or thyroid antibodies in Hashimoto patients without celiac [C5][C6][C7]. If celiac is present, gluten avoidance does help — partly through restored levothyroxine absorption [C2].
Do I still need a biopsy if antibodies are positive? In adults, yes — the duodenal biopsy is still the standard confirmation, particularly because the diagnosis commits the patient to a lifelong dietary change [C4].
Why does my levothyroxine dose drop after starting a gluten-free diet? The damaged jejunum was malabsorbing the drug. As the mucosa heals over weeks to months, more of each tablet is absorbed, and your endocrinologist will lower the dose to avoid over-replacement [C2][C5][C8].
Bottom line
Hashimoto patients sit in an autoimmune cluster that meaningfully raises the risk of celiac disease — roughly 3-7 fold above the general population [C1][C3]. Screening with tTG-IgA plus total IgA is reasonable at diagnosis or when thyroid control is unexpectedly poor on adequate levothyroxine dosing [C3][C4]. In confirmed celiac, a strict lifelong gluten-free diet is mandatory and often improves levothyroxine absorption and TSH stability [C2][C5][C8]. In the absence of celiac, the current evidence does not support gluten-free dieting as a treatment for Hashimoto [C5][C6][C7]. Talk to your endocrinologist about screening if your story fits the high-risk profile.
Sources
- [C1] Roy A et al. Prevalence of Celiac Disease in Patients with Autoimmune Thyroid Disease: A Meta-Analysis. Thyroid. 2016. PubMed: 27256300
- [C2] Sategna-Guidetti C et al. Prevalence of thyroid disorders in untreated adult celiac disease patients and effect of gluten withdrawal: an Italian multicenter study. Am J Gastroenterol. 2001. PubMed: 11280546
- [C3] Ashok T et al. Celiac Disease and Autoimmune Thyroid Disease: The Two Peas in a Pod. Cureus. 2022. PubMed: 35911325
- [C4] Murray JA et al. Celiac Disease. 2026. PubMed: 41950475
- [C5] Malandrini S et al. What about TSH and Anti-Thyroid Antibodies in Patients with Autoimmune Thyroiditis and Celiac Disease Using a Gluten-Free Diet? A Systematic Review. 2022. PubMed: 35458242
- [C6] Piticchio T et al. Effect of gluten-free diet on autoimmune thyroiditis progression in patients with no symptoms or histology of celiac disease: a meta-analysis. 2023. PubMed: 37554764
- [C7] Araújo EMQ et al. Effects of Gluten-Free Diet in Non-Celiac Hashimoto's Thyroiditis: A Systematic Review and Meta-Analysis. 2025. PubMed: 41228508
- [C8] Jonklaas J et al. Guidelines for the treatment of hypothyroidism. Thyroid. 2014;24(12):1670–1751. PubMed: 25266247
For educational purposes only. Not medical advice. Always consult your healthcare provider.
Related reading
Continue with Thyra context
Educational resources to help you understand food, routines, and tracking. Not medical advice or treatment recommendations.
Sources
- A
- A
- AAshok T et al. 2022 — Celiac Disease and Autoimmune Thyroid Disease: The Two Peas in a Pod· 2022 · narrative-review
- AMurray JA et al. 2026 — Celiac Disease· 2026 · narrative-review
- A
- A
- A
- AJonklaas J et al. 2014 — Guidelines for the treatment of hypothyroidism (American Thyroid Association)· 2014 · clinical-practice-guideline